The merger realizes the shared strategic goal of becoming the leading
Global Medical Device and Medical Technology Focused CRO

BILTHOVEN, Netherlands & MARLBOROUGH, Mass.–(BUSINESS WIRE)–Factory-CRO
Group, a leading global contract research organization (CRO) focused
on medical devices and in vitro diagnostics (IVDs), and Boston
Biomedical Associates (BBA) a premier full-service Medical
Device/Biotechnology CRO and Consultancy based in the United States
announce that they have merged the organizations.

The merger further advances the shared strategic vision to become the
leading Global Medical Device and Medical Technology focused CRO.
Following the recent acquisitions of MileStone Research Organization,
Five Corners, and Clinical Device Group the Factory-CRO Group now has
specialized operations and expertise in the United States, Australia/New
Zealand, and Europe. This global expansion coupled with the diverse
medical therapeutic expertise provides a means to efficiently service
clients.

“BBA is excited to join Factory-CRO’s worldwide group as it will allow
us to expand our comprehensive service offering to our clients,” said
Lauren Baker, PhD, President and CEO of BBA. “The alignment of
Factory-CRO and BBA’s core values and approach to engagements combined
with our collective therapeutic competencies ensures that our clients
now have improved access to our global clinical trial execution
resources, and our regulatory and medical expertise.” Dr. Baker then
added, “We are able to fully support our clients as their needs evolve
and they strive to help patients globally.”

“We are honored to have the BBA team join the Factory-CRO Group,” said
Dirk Meijer, MD, MSc,PhD, Factory-CRO CEO. “BBA’s ability to provide
CRO/Consultative service in North America was a missing link in our
global offerings.” Dr. Meijer then added, “Our clients have consistently
asked us to expand our offerings in North America. This merger allows us
to provide our specialized expertise and a continued commitment to the
highest level of customized service to a larger audience. Now we are the
only Medical Device and Medical Technology CRO that offers services in
United States, Europe, Australia and New Zealand. We operate from our
own offices located within each region housed with employees that have
refined expertise to meet our unique client needs.”

About Factory-CRO Group:
Factory-CRO
Group is a leading, full-service contract research organization focused
on the management of clinical studies for medical devices, IVDs,
biologics and device-drug combination products internationally. Founded
in 1992, the business offers a full suite of trial management services
to its global client base across a broad range of therapeutic areas,
including orthopedic, cardiovascular, dermatology and aesthetics.
Current members of Factory-CRO Group are: BBA, Five Corners CRO,
Milestone Research group and Factory-CRO.

For more information about Factory-CRO, visit their website, www.factory-cro.com
or contact Joris Bannenberg, MD, PhD, Factory-CRO’s CMO:

Joris Bannenberg, MD, PhD
CMO
j.bannenberg@factory-cro.com
+31
30 229 2727 (x108)

About Boston Biomedical Associates:
Boston
Biomedical Associates (BBA) is a premier full-service Medical
Device/Biotechnology CRO and Consultancy firm. Founded in 2000, by
Lauren Baker, Ph.D., this leading CRO has earned a reputation for its
comprehensive approach to clinical trial execution services to its
global client base across a broad range of therapeutic areas, including
orthopedic, cardiovascular, endocrine and neurologic disorders.

For more information about BBA, visit their website, www.bbacro.com
or contact Mack Rubley, PhD, BBA’s Vice President of Business
Development and Marketing:

Mack D. Rubley, PhD
VP, Business Development and Marketing
702-808-3494
mrubley@bbacro.com

Contacts

Joris Bannenberg, MD, PhD
CMO
j.bannenberg@factory-cro.com
+31
30 229 2727 (x108)

Mack D. Rubley, PhD
VP, Business Development and Marketing
702-808-3494
mrubley@bbacro.com